ABT vs CALM · P/E 25, rev $44.33B vs P/E 5.2, rev $2.91B
Abbott Laboratories (ABT) versus Cal-Maine Foods Inc (CALM) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Cal-Maine Foods Inc (CALM) is a farm products company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CALM revenue for 2026-05-30 was $2.91B. Net income was $316.7M. Revenue was down 31.7% from 2025-05-31 to 2026-05-30. CALM currently screens at market cap $3.54B and trailing P/E 5.2.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CALM currently screens at market cap $3.54B and trailing P/E 5.2.
Not investment advice. Open the ABT and CALM stock pages for the full models.
Not investment advice.